An increased ratio of MDSCs to memory CD8 effector T cells was observed in patients with severe ARDS due to COVID-19 compared to moderate COVID-19 patients, and the COVID-19 severity is correlated directly with lymphopenia and enlarged ARG1 activity [87]. This evidence concerns the gene CD8A and COVID-19.